Affinity Interactions Between Insulin and Quadruplex DNA

胰岛素和四链体 DNA 之间的亲和力相互作用

基本信息

  • 批准号:
    7025052
  • 负责人:
  • 金额:
    $ 21.73万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2005
  • 资助国家:
    美国
  • 起止时间:
    2005-03-01 至 2008-02-28
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): The proposed research initiates a new line of investigation into nuclear mechanisms of insulin expression that involve direct association of insulin and insulin-like growth factors (IGFs) with genomic G-quartet DNA in the insulin-linked polymorphic region (ILPR) of the human insulin gene promoter. The proposal is based on the discovery of in vitro affinity capture of insulin by G-quartet DNA oligonucleotides with the ILPR repeat sequence. It is supported by reports suggesting that nuclear accumulation of insulin and IGFs may play a role in regulation of transcription, as well as by growing evidence of the biological significance of G-quartet formation in genomic DNA. The results could lead to the identification of new genomic targets for treatment of diabetes and its complications. The specific aim of this R21 proposal is to determine if human insulin and IGFs exhibit specific, affinity binding in vitro to G-quartet DNA oligonucleotides corresponding to the ILPR variants. It takes a new approach to screening interactions between proteins and particular oligonucleotide structural motifs using DNA arrays and MALDI mass spectrometric detection. Effects of stabilizing cations, zinc, pH, porphyrin complexation, intra- vs. intermolecular G-quartet formation, tandem repeat number and protein concentration will be studied. When affinity binding is observed, solution studies will be preformed to provide a more quantitative measure of binding affinity. Milestones include demonstration of (1) at least 103- fold greater affinity between insulin proteins and G-quartet ILPR variants than between insulin proteins and non-G-quartet ILPR variants, and between albumin and G-quartet ILPR variants, (2) at least 10-fold greater affinity between insulin proteins and G-quartet ILPR variants relative to other G-quartet oligonucleotides, and (3) significant differences in binding affinities of insulin proteins among the different G-quartet ILPR variants. The results will lead to the design of new affinity binding ligands for a collaborative R01 proposal to perform in vivo studies in cells and transgenic animals.
描述(由申请人提供):拟议的研究启动了对胰岛素表达的核机制的新研究,涉及胰岛素链接多态性区域(ILPR)中胰岛素连接的多态性区域(ILPR)中胰岛素和类胰岛素样生长因子(IGF)的直接关联。该提案基于与ILPR重复序列的G-Quartet DNA寡核苷酸对胰岛素的体外亲和力捕获。该报告表明,胰岛素和IGF的核积累可能在转录调节中起作用,以及越来越多地证明G Quartet形成在基因组DNA中的生物学意义。结果可能导致鉴定出用于治疗糖尿病及其并发症的新基因组靶标。 该R21提案的具体目的是确定人类胰岛素和IGF是否在体外与与ILPR变体相对应的G-四分之一DNA寡核苷酸表现出特定的亲和力结合。它采用了一种新的方法来使用DNA阵列和MALDI质谱检测来筛选蛋白质与特定寡核苷酸结构基序之间的相互作用。将研究稳定阳离子,锌,pH,卟啉络合,内部与分子间G-四分之一形成,串联重复数和蛋白质浓度的影响。当观察到亲和力结合时,将进行溶液研究,以提供更定量的结合亲和力度量。 Milestones include demonstration of (1) at least 103- fold greater affinity between insulin proteins and G-quartet ILPR variants than between insulin proteins and non-G-quartet ILPR variants, and between albumin and G-quartet ILPR variants, (2) at least 10-fold greater affinity between insulin proteins and G-quartet ILPR variants relative to other G-quartet寡核苷酸和(3)不同G-Quartet ILPR变体之间胰岛素蛋白的结合亲和力的显着差异。结果将导致设计新的亲和力结合配体,用于协作R01提案,以在细胞和转基因动物中进行体内研究。

项目成果

期刊论文数量(4)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Association of insulin-like growth factor 2 with the insulin-linked polymorphic region in cultured fetal thymus cells.
胰岛素样生长因子 2 与培养的胎儿胸腺细胞中胰岛素相关多态性区域的关联。
  • DOI:
    10.1021/bi900958x
  • 发表时间:
    2009
  • 期刊:
  • 影响因子:
    2.9
  • 作者:
    Wang,Yuexi;Zhang,Huiping;Ligon,LeeA;McGown,LindaB
  • 通讯作者:
    McGown,LindaB
A genome-inspired DNA ligand for the affinity capture of insulin and insulin-like growth factor-2.
  • DOI:
    10.1002/jssc.200900060
  • 发表时间:
    2009-05
  • 期刊:
  • 影响因子:
    3.1
  • 作者:
    Xiao, Junfeng;Carter, Jennifer A.;Frederick, Kimberley A.;McGown, Linda B.
  • 通讯作者:
    McGown, Linda B.
Mass spectrometric determination of ILPR G-quadruplex binding sites in insulin and IGF-2.
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Linda B. Mc GOWN其他文献

Linda B. Mc GOWN的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Linda B. Mc GOWN', 18)}}的其他基金

Genome-Inspired Pathway to Aptamer Discovery
基因组启发的适体发现途径
  • 批准号:
    9313901
  • 财政年份:
    2015
  • 资助金额:
    $ 21.73万
  • 项目类别:
Genome-Inspired Pathway to Aptamer Discovery
基因组启发的适体发现途径
  • 批准号:
    9134167
  • 财政年份:
    2015
  • 资助金额:
    $ 21.73万
  • 项目类别:
Genome-Inspired Pathway to Aptamer Discovery
基因组启发的适体发现途径
  • 批准号:
    8961141
  • 财政年份:
    2015
  • 资助金额:
    $ 21.73万
  • 项目类别:
Two-Dimensional Microfluidic Platform for Rapid DNA Separation by Fragment Length
用于按片段长度快速分离 DNA 的二维微流控平台
  • 批准号:
    8531295
  • 财政年份:
    2012
  • 资助金额:
    $ 21.73万
  • 项目类别:
Two-Dimensional Microfluidic Platform for Rapid DNA Separation by Fragment Length
用于按片段长度快速分离 DNA 的二维微流控平台
  • 批准号:
    8717690
  • 财政年份:
    2012
  • 资助金额:
    $ 21.73万
  • 项目类别:
Two-Dimensional Microfluidic Platform for Rapid DNA Separation by Fragment Length
用于按片段长度快速分离 DNA 的二维微流控平台
  • 批准号:
    8352837
  • 财政年份:
    2012
  • 资助金额:
    $ 21.73万
  • 项目类别:
Hybridization of Promoter DNA Targets in Chromatin to Discover Regulatory Protein
染色质中的启动子 DNA 靶标杂交以发现调节蛋白
  • 批准号:
    7892575
  • 财政年份:
    2009
  • 资助金额:
    $ 21.73万
  • 项目类别:
Hybridization of Promoter DNA Targets in Chromatin to Discover Regulatory Protein
染色质中的启动子 DNA 靶标杂交以发现调节蛋白
  • 批准号:
    7692463
  • 财政年份:
    2009
  • 资助金额:
    $ 21.73万
  • 项目类别:
Affinity Interactions Between Insulin and Quadruplex DNA
胰岛素和四链体 DNA 之间的亲和力相互作用
  • 批准号:
    6903343
  • 财政年份:
    2005
  • 资助金额:
    $ 21.73万
  • 项目类别:
Proteomic Approach to G-Quartets and Cell Aging
G-四重奏和细胞衰老的蛋白质组学方法
  • 批准号:
    6576620
  • 财政年份:
    2002
  • 资助金额:
    $ 21.73万
  • 项目类别:

相似国自然基金

基于CRISPR生物技术与双传感效应的光纤传感器及其超灵敏猴痘病毒基因检测研究
  • 批准号:
    62305224
  • 批准年份:
    2023
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目
基于流感病毒结构和功能仿生基础的生物技术药物研究
  • 批准号:
    82130100
  • 批准年份:
    2021
  • 资助金额:
    291 万元
  • 项目类别:
    重点项目
生物技术启发的拓扑合成高分子制备及构效关系研究
  • 批准号:
  • 批准年份:
    2021
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目
定制工程细胞合成生物技术及多样性应用研究
  • 批准号:
  • 批准年份:
    2021
  • 资助金额:
    58 万元
  • 项目类别:
下一代工业生物技术:理论与实践
  • 批准号:
    32130001
  • 批准年份:
    2021
  • 资助金额:
    291 万元
  • 项目类别:
    重点项目

相似海外基金

High-throughput functional analysis and clinical relevance of all possible variants of a gene
基因所有可能变异的高通量功能分析和临床相关性
  • 批准号:
    10601908
  • 财政年份:
    2023
  • 资助金额:
    $ 21.73万
  • 项目类别:
Gene Therapy Clinical Candidate Development for Carbamoyl Phosphate Synthetase Deficiency
氨基甲酰磷酸合成酶缺乏症的基因治疗临床候选药物开发
  • 批准号:
    10540348
  • 财政年份:
    2022
  • 资助金额:
    $ 21.73万
  • 项目类别:
Gene Therapy Clinical Candidate Development for Carbamoyl Phosphate Synthetase Deficiency
氨基甲酰磷酸合成酶缺乏症的基因治疗临床候选药物开发
  • 批准号:
    10339836
  • 财政年份:
    2022
  • 资助金额:
    $ 21.73万
  • 项目类别:
REDfly: The regulatory sequence resource for Drosophila and other insects
REDfly:果蝇和其他昆虫的调控序列资源
  • 批准号:
    10267371
  • 财政年份:
    2021
  • 资助金额:
    $ 21.73万
  • 项目类别:
Regulatory mechanisms of rare non-coding variation in neurodegeneration-associated loci
神经退行性变相关位点罕见非编码变异的调控机制
  • 批准号:
    10686043
  • 财政年份:
    2021
  • 资助金额:
    $ 21.73万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了